Literature DB >> 21602832

Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development.

Ulf-Håkan Stenman1.   

Abstract

Entities:  

Year:  2011        PMID： 21602832      PMCID： PMC3739629          DOI： 10.1038/aja.2011.45

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  28 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.

Authors:  J-P Wiksten; J Lundin; S Nordling; A Kokkola; U-H Stenman; C Haglund
Journal:  Histopathology       Date:  2005-04       Impact factor: 5.087

3.  Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer.

Authors:  Katri A Leinonen; Teemu T Tolonen; Hazel Bracken; Ulf-Håkan Stenman; Teuvo L J Tammela; Outi R Saramäki; Tapio Visakorpi
Journal:  Clin Cancer Res       Date:  2010-05-04       Impact factor: 12.531

4.  Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Authors:  P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

5.  Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.

Authors:  Annukka Paju; Kristina Hotakainen; Yue Cao; Timo Laurila; Virgil Gadaleanu; Akseli Hemminki; Ulf-Håkan Stenman; Anders Bjartell
Journal:  Eur Urol       Date:  2007-02-05       Impact factor: 20.096

6.  Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.

Authors:  Alexander Gaber; Björn Nodin; Kristina Hotakainen; Elise Nilsson; Ulf-Håkan Stenman; Anders Bjartell; Helgi Birgisson; Karin Jirström
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

Review 7.  Tumor-associated trypsin inhibitor.

Authors:  Ulf-Håkan Stenman
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

8.  Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury.

Authors:  M Ogawa; K Matsuda; T Shibata; Y Matsuda; T Ukai; M Ohta; T Mori
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1985-11

9.  Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus Doxorubicin in the treatment of metastatic castration-resistant prostate cancer.

Authors:  Susan F Slovin; W Kevin Kelly; Andrew Wilton; Michael Kattan; Patricia Myskowski; John Mendelsohn; Howard I Scher
Journal:  Clin Genitourin Cancer       Date:  2009-10       Impact factor: 2.872

10.  Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.

Authors:  T Niinobu; M Ogawa; A Murata; J Nishijima; T Mori
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307
View more
  7 in total

1.  Gingipains of Porphyromonas gingivalis Affect the Stability and Function of Serine Protease Inhibitor of Kazal-type 6 (SPINK6), a Tissue Inhibitor of Human Kallikreins.

Authors:  Karolina Plaza; Magdalena Kalinska; Oliwia Bochenska; Ulf Meyer-Hoffert; Zhihong Wu; Jan Fischer; Katherine Falkowski; Laura Sasiadek; Ewa Bielecka; Barbara Potempa; Andrzej Kozik; Jan Potempa; Tomasz Kantyka
Journal:  J Biol Chem       Date:  2016-06-27       Impact factor: 5.157

2.  Spink13, an epididymis-specific gene of the Kazal-type serine protease inhibitor (SPINK) family, is essential for the acrosomal integrity and male fertility.

Authors:  Li Ma; Heguo Yu; Zimei Ni; Shuanggang Hu; Wubin Ma; Chen Chu; Qiang Liu; Yonglian Zhang
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

3.  Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men.

Authors:  Desta A Beyene; Tammey J Naab; Norma F Kanarek; Victor Apprey; Ashwini Esnakula; Farahan A Khan; Marc R Blackman; Collis A Brown; Tamaro S Hudson
Journal:  Prostate       Date:  2018-04-22       Impact factor: 4.104

4.  Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker.

Authors:  Aileen Marshall; Margus Lukk; Claudia Kutter; Susan Davies; Graeme Alexander; Duncan T Odom
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

5.  Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.

Authors:  Fei Chen; Qilai Long; Da Fu; Dexiang Zhu; Yan Ji; Liu Han; Boyi Zhang; Qixia Xu; Bingjie Liu; Yan Li; Shanshan Wu; Chen Yang; Min Qian; Jianmin Xu; Suling Liu; Liu Cao; Y Eugene Chin; Eric W-F Lam; Jean-Philippe Coppé; Yu Sun
Journal:  Nat Commun       Date:  2018-10-17       Impact factor: 14.919

6.  SPINK1 is a prognosis predicting factor of non-small cell lung cancer and regulates redox homeostasis.

Authors:  Maoqing Guo; Xuan Zhou; Xiao Han; Youwen Zhang; Luning Jiang
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

7.  Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.

Authors:  Christine Mehner; Erin Miller; Alexandra Hockla; Mathew Coban; S John Weroha; Derek C Radisky; Evette S Radisky
Journal:  Oncogene       Date:  2020-09-14       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.